Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF

R. Munivenkatappa, A. Haririan, J. C. Papadimitriou, C. B. Drachenberg, M. Dinits-Pensy, D. K. Klassen

Research output: Contribution to journalArticle

Abstract

Sirolimus is associated with prolonged delayed graft function (DGF) following renal transplantation and exacerbation of proteinuria. We assessed renal allograft biopsies from DGF patients treated with de novo sirolimus (n = 10) for renal tubular cell and podocyte apoptosis and expression of activated caspase-3, Bcl-2, and mTOR and compared them to biopsies from DGF patients not receiving sirolimus (n =15). Both groups received mycophenolate mofetil, prednisone and antibody induction. Apoptosis was assessed using terminal deoxynucleodidyl transferase mediated dUTP nick end labeling (TUNEL) staining. Caspase-3, Bcl-2, and mTOR expression were assessed by immunohistochemistry. Sirolimus treated patients had 334±69 TUNEL positive cells per 5 high power fields compared to 5.5±2.9 TUNEL positive cells in control patients (p<0.001). The number of TUNEL positive cells correlated with tubular architectural disruption. Expression of activated caspase-3, Bcl-2, or activated mTOR did not differ between groups. 60% of biopsies from sirolimus treated patients compared to 7% of biopsies from controls showed diffuse podocyte apoptosis (p = 0.007). There was no podocyte expression of activated mTOR, activated caspase-3, or Bcl-2 in either group. These data suggest that DGF patients treated with sirolimus have increased renal tubular cell apoptosis and podocyte apoptosis.

Original languageEnglish (US)
Pages (from-to)189-196
Number of pages8
JournalHistology and Histopathology
Volume25
Issue number2
StatePublished - Feb 1 2010

Keywords

  • Apoptosis
  • Delayed graft function
  • Kidney
  • Podocyte
  • Sirolimus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Fingerprint Dive into the research topics of 'Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF'. Together they form a unique fingerprint.

  • Cite this

    Munivenkatappa, R., Haririan, A., Papadimitriou, J. C., Drachenberg, C. B., Dinits-Pensy, M., & Klassen, D. K. (2010). Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF. Histology and Histopathology, 25(2), 189-196.